CIK 0001840574
VERV Verve Therapeutics, Inc.
Insider trading from SEC Form 4. Last filing Jul 28, 2025.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
15
with a Form 4 at this company
Signals
Open-market buys and sells at Verve Therapeutics, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 0Weak | Andrew D. Ashe See Remarks sell | $11k 2,681 shares | -1% | - | |
| 7Weak | Allison Dorval Chief Financial Officer sell | $14k 3,350 shares | -20% | - | |
| 11Weak | Sekar Kathiresan Chief Executive Officer sell | $41k 9,822 shares | -3% | - | |
| 0Weak | Troy Lister Chief Scientific Officer sell | $9,084 2,189 shares | -24% | - | |
| 0Weak | Joan Nickerson Chief Administrative Officer sell | $12k 2,777 shares | -14% | - | |
| 0Weak | Jason Politi Chief Technical Ops. Off. sell | $13k 3,235 shares | -19% | - | |
| 7Weak | Allison Dorval Chief Financial Officer sell | $3,130 555 shares | -9% | - |
Transactions
The last 68 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 25, 2025 | Burt A Adelman director | UTender of shares Common Stockindirect: Burt A Adelman 2002 Trust | -428,326 | - | - | 0 | Jul 28, 2025 |
| Jul 25, 2025 | Allison Dorval Chief Financial Officer | UTender of shares Common Stock | -13,280 | - | - | 0 | Jul 28, 2025 |
| Jul 25, 2025 | Gv 2017 Gp, L.l.c. owner | UTender of shares Common Stockindirect: By GV 2017 L.P. | -6,108,442 | - | - | 0 | Jul 28, 2025 |
| Jul 25, 2025 | Alexander Cumbo director | DDisposition to issuer Stock Option (right to buy)derivative | -136,139 | - | - | 0 | Jul 28, 2025 |
| Jul 25, 2025 | Andrew D. Ashe See Remarks | UTender of shares Common Stock | -348,828 | - | - | 0 | Jul 28, 2025 |
| Jul 25, 2025 | Lonnel Coats director | DDisposition to issuer Stock Option (right to buy)derivative | -136,139 | - | - | 0 | Jul 28, 2025 |
| Jul 25, 2025 | Burt A Adelman director | DDisposition to issuer Stock Option (right to buy)derivative | -136,139 | - | - | 0 | Jul 28, 2025 |
| Jul 25, 2025 | Allison Dorval Chief Financial Officer | DDisposition to issuer Stock Option (right to buy)derivative | -258,000 | - | - | 0 | Jul 28, 2025 |
| Jul 25, 2025 | Alexander Cumbo director | DDisposition to issuer Stock Option (right to buy)derivative | -42,200 | - | - | 0 | Jul 28, 2025 |
| Jul 25, 2025 | Lonnel Coats director | DDisposition to issuer Stock Option (right to buy)derivative | -42,200 | - | - | 0 | Jul 28, 2025 |
| Jul 25, 2025 | Andrew D. Ashe See Remarks | DDisposition to issuer Stock Option (right to buy)derivative | -225,000 | - | - | 0 | Jul 28, 2025 |
| Jul 25, 2025 | Gv 2017 Gp, L.l.c. owner | UTender of shares Common Stockindirect: By GV 2019 L.P. | -4,260,047 | - | - | 0 | Jul 28, 2025 |
| Jul 25, 2025 | Andrew D. Ashe See Remarks | DDisposition to issuer Restricted Stock Unitsderivative | -40,000 | - | - | 0 | Jul 28, 2025 |
| Jul 25, 2025 | Gv 2017 Gp, L.l.c. owner | UTender of shares Common Stockindirect: By GV 2023, L.P. | -1,800,000 | - | - | 0 | Jul 28, 2025 |
| Jul 25, 2025 | Burt A Adelman director | DDisposition to issuer Stock Option (right to buy)derivative | -42,200 | - | - | 0 | Jul 28, 2025 |
| Jul 25, 2025 | Allison Dorval Chief Financial Officer | DDisposition to issuer Stock Option (right to buy)derivative | -75,000 | - | - | 0 | Jul 28, 2025 |
| Jul 25, 2025 | Andrew D. Ashe See Remarks | DDisposition to issuer Restricted Stock Unitsderivative | -27,000 | - | - | 0 | Jul 28, 2025 |
| Jul 25, 2025 | Burt A Adelman director | DDisposition to issuer Stock Option (right to buy)derivative | -43,198 | - | - | 0 | Jul 28, 2025 |
| Jul 25, 2025 | Allison Dorval Chief Financial Officer | DDisposition to issuer Restricted Stock Unitsderivative | -45,000 | - | - | 0 | Jul 28, 2025 |
| Jul 25, 2025 | Andrew D. Ashe See Remarks | DDisposition to issuer Stock Option (right to buy)derivative | -107,997 | - | - | 0 | Jul 28, 2025 |
| Jul 25, 2025 | Allison Dorval Chief Financial Officer | DDisposition to issuer Restricted Stock Unitsderivative | -33,750 | - | - | 0 | Jul 28, 2025 |
| Jul 25, 2025 | Andrew D. Ashe See Remarks | DDisposition to issuer Stock Option (right to buy)derivative | -153,278 | - | - | 0 | Jul 28, 2025 |
| Jul 25, 2025 | Allison Dorval Chief Financial Officer | DDisposition to issuer Restricted Stock Unitsderivative | -1,875 | - | - | 0 | Jul 28, 2025 |
| Jul 25, 2025 | Allison Dorval Chief Financial Officer | DDisposition to issuer Stock Option (right to buy)derivative | -180,000 | - | - | 0 | Jul 28, 2025 |
| Jul 25, 2025 | Andrew D. Ashe See Remarks | DDisposition to issuer Stock Option (right to buy)derivative | -26,999 | - | - | 0 | Jul 28, 2025 |
| Jul 25, 2025 | Andrew D. Ashe See Remarks | DDisposition to issuer Stock Option (right to buy)derivative | -150,000 | - | - | 0 | Jul 28, 2025 |
| Jun 5, 2025 | Ourania Tatsis director | AGrant or award Stock Option (right to buy)derivative | +42,200 | $0.00 | $0 | 42,200 | Jun 6, 2025 |
| Jun 5, 2025 | Krishna Yeshwant director, owner | AGrant or award Stock Option (right to buy)derivative | +42,200 | $0.00 | $0 | 42,200 | Jun 6, 2025 |
| Jun 5, 2025 | Jodie Pope Morrison director | AGrant or award Stock Option (right to buy)derivative | +42,200 | $0.00 | $0 | 42,200 | Jun 6, 2025 |
| Jun 5, 2025 | Sheila Mikhail director | AGrant or award Stock Option (right to buy)derivative | +42,200 | $0.00 | $0 | 42,200 | Jun 6, 2025 |
| Jun 5, 2025 | Michael F MacLean director | AGrant or award Stock Option (right to buy)derivative | +42,200 | $0.00 | $0 | 42,200 | Jun 6, 2025 |
| Jun 5, 2025 | Alexander Cumbo director | AGrant or award Stock Option (right to buy)derivative | +42,200 | $0.00 | $0 | 42,200 | Jun 6, 2025 |
| Jun 5, 2025 | Lonnel Coats director | AGrant or award Stock Option (right to buy)derivative | +42,200 | $0.00 | $0 | 42,200 | Jun 6, 2025 |
| Jun 5, 2025 | Burt A Adelman director | AGrant or award Stock Option (right to buy)derivative | +42,200 | $0.00 | $0 | 42,200 | Jun 6, 2025 |
| Apr 1, 2025 | Jason Politi Chief Technical Ops. Off. | MOption exercise Common Stock10b5-1 | +8,815 | - | - | 17,461 | Apr 3, 2025 |
| Apr 1, 2025 | Joan Nickerson Chief Administrative Officer | MOption exercise Common Stock10b5-1 | +9,315 | - | - | 20,197 | Apr 3, 2025 |
| Apr 1, 2025 | Troy Lister Chief Scientific Officer | MOption exercise Common Stock10b5-1 | +7,340 | - | - | 9,141 | Apr 3, 2025 |
| Apr 1, 2025 | Sekar Kathiresan Chief Executive Officer | MOption exercise Common Stock10b5-1 | +33,000 | - | - | 356,508 | Apr 3, 2025 |
| Apr 1, 2025 | Allison Dorval Chief Financial Officer | MOption exercise Common Stock10b5-1 | +11,250 | - | - | 16,630 | Apr 3, 2025 |
| Apr 1, 2025 | Andrew D. Ashe See Remarks | MOption exercise Common Stock10b5-1 | +9,000 | - | - | 351,509 | Apr 3, 2025 |
| Apr 2, 2025 | Andrew D. Ashe See Remarks | SOpen-market sale Common Stock10b5-1 | -2,681 | $4.15 | $11k | 348,828 | Apr 3, 2025 |
| Apr 2, 2025 | Jason Politi Chief Technical Ops. Off. | SOpen-market sale Common Stock10b5-1 | -3,235 | $4.15 | $13k | 14,226 | Apr 3, 2025 |
| Apr 2, 2025 | Joan Nickerson Chief Administrative Officer | SOpen-market sale Common Stock10b5-1 | -2,777 | $4.15 | $12k | 17,420 | Apr 3, 2025 |
| Apr 2, 2025 | Troy Lister Chief Scientific Officer | SOpen-market sale Common Stock10b5-1 | -2,189 | $4.15 | $9,084 | 6,952 | Apr 3, 2025 |
| Apr 2, 2025 | Sekar Kathiresan Chief Executive Officer | SOpen-market sale Common Stock10b5-1 | -9,822 | $4.15 | $41k | 346,686 | Apr 3, 2025 |
| Apr 2, 2025 | Allison Dorval Chief Financial Officer | SOpen-market sale Common Stock10b5-1 | -3,350 | $4.15 | $14k | 13,280 | Apr 3, 2025 |
| Apr 1, 2025 | Allison Dorval Chief Financial Officer | MOption exercise Restricted Stock Unitsderivative10b5-1 | -11,250 | $0.00 | $0 | 33,750 | Apr 3, 2025 |
| Apr 1, 2025 | Andrew D. Ashe See Remarks | MOption exercise Restricted Stock Unitsderivative10b5-1 | -9,000 | $0.00 | $0 | 27,000 | Apr 3, 2025 |
| Apr 1, 2025 | Troy Lister Chief Scientific Officer | MOption exercise Restricted Stock Unitsderivative10b5-1 | -3,315 | $0.00 | $0 | 6,630 | Apr 3, 2025 |
| Apr 1, 2025 | Jason Politi Chief Technical Ops. Off. | MOption exercise Restricted Stock Unitsderivative10b5-1 | -3,315 | $0.00 | $0 | 6,630 | Apr 3, 2025 |
| Apr 1, 2025 | Joan Nickerson Chief Administrative Officer | MOption exercise Restricted Stock Unuitsderivative10b5-1 | -3,315 | $0.00 | $0 | 6,630 | Apr 3, 2025 |
| Apr 1, 2025 | Jason Politi Chief Technical Ops. Off. | MOption exercise Restricted Stock Unitsderivative10b5-1 | -5,500 | $0.00 | $0 | 16,500 | Apr 3, 2025 |
| Apr 1, 2025 | Joan Nickerson Chief Administrative Officer | MOption exercise Restricted Stock Unitsderivative10b5-1 | -6,000 | $0.00 | $0 | 18,000 | Apr 3, 2025 |
| Apr 1, 2025 | Troy Lister Chief Scientific Officer | MOption exercise Restricted Stock Unitsderivative10b5-1 | -4,025 | $0.00 | $0 | 12,075 | Apr 3, 2025 |
| Apr 1, 2025 | Sekar Kathiresan Chief Executive Officer | MOption exercise Restricted Stock Unitsderivative10b5-1 | -33,000 | $0.00 | $0 | 99,000 | Apr 3, 2025 |
| Jan 8, 2025 | Andrew D. Ashe See Remarks | AGrant or award Stock Option (right to buy)derivative | +225,000 | $0.00 | $0 | 225,000 | Jan 10, 2025 |
| Jan 8, 2025 | Allison Dorval Chief Financial Officer | AGrant or award Stock Option (right to buy)derivative | +258,000 | $0.00 | $0 | 258,000 | Jan 10, 2025 |
| Jan 8, 2025 | Sekar Kathiresan Chief Executive Officer | AGrant or award Stock Option (right to buy)derivative | +488,000 | $0.00 | $0 | 488,000 | Jan 10, 2025 |
| Jan 8, 2025 | Andrew D. Ashe See Remarks | AGrant or award Restricted Stock Unitsderivative | +40,000 | $0.00 | $0 | 40,000 | Jan 10, 2025 |
| Jan 8, 2025 | Allison Dorval Chief Financial Officer | AGrant or award Restricted Stock Unitsderivative | +45,000 | $0.00 | $0 | 45,000 | Jan 10, 2025 |
| Jan 8, 2025 | Sekar Kathiresan Chief Executive Officer | AGrant or award Restricted Stock Unitsderivative | +120,000 | $0.00 | $0 | 120,000 | Jan 10, 2025 |
| Jan 8, 2025 | Allison Dorval Chief Financial Officer | AGrant or award Stock Option (right to buy)derivative | +75,000 | $0.00 | $0 | 75,000 | Jan 10, 2025 |
| Jan 8, 2025 | Sekar Kathiresan Chief Executive Officer | AGrant or award Stock Option (right to buy)derivative | +150,000 | $0.00 | $0 | 150,000 | Jan 10, 2025 |
| Dec 4, 2024 | Sekar Kathiresan Chief Executive Officer | GGift Common Stock | -30,000 | $0.00 | $0 | 323,508 | Dec 4, 2024 |
| Dec 4, 2024 | Sekar Kathiresan Chief Executive Officer | GGift Common Stockindirect: Sekar Kathiresan 2021 Irrevocable Trust | +30,000 | $0.00 | $0 | 110,997 | Dec 4, 2024 |
| Nov 29, 2024 | Allison Dorval Chief Financial Officer | MOption exercise Common Stock | +1,875 | - | - | 5,935 | Dec 3, 2024 |
| Dec 2, 2024 | Allison Dorval Chief Financial Officer | SOpen-market sale Common Stock | -555 | $5.64 | $3,130 | 5,380 | Dec 3, 2024 |
| Nov 29, 2024 | Allison Dorval Chief Financial Officer | MOption exercise Restricted Stock Unitsderivative | -1,875 | $0.00 | $0 | 1,875 | Dec 3, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Burt A Adelmandirector
- Andrew D. AsheSee Remarks
- Lonnel Coatsdirector
- Alexander Cumboceo, president, officer, director
- Allison DorvalChief Financial Officer
- Gv 2017 Gp, L.l.c.owner
- Sekar KathiresanChief Executive Officer
- Troy ListerChief Scientific Officer
- Michael F MacLeancfo, officer, director
- Sheila Mikhaildirector
- Jodie Pope Morrisondirector
- Joan NickersonChief Administrative Officer
- Jason PolitiChief Technical Ops. Off.
- Ourania Tatsisdirector
- Krishna Yeshwantdirector, owner
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.